In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...

TUESDAY, July 2, 2024 -- Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide...

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Novo Nordisk’s popular weight loss drug Wegovy has been approved for the treatment of severe obesity in China. “We can confirm that Wegovy has...

Cleveland Clinic study reveals that weight loss surgery significantly reduces the risk of heart complications by 42% and the risk of death by 37% in...

THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA),...

TUESDAY, June 25, 2024 -- Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk...

A recent study reveals that using sound to stimulate brain waves could significantly improve sleep quality for those suffering from dementia or...